BODIPY Mitochondrial Labeling Compound via Extraction Principle

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional methods for labeling mitochondria, such as using green fluorescence protein, are limited by gene mutation risks due to the large size of the virus and random DNA injection, necessitating a low-molecular-weight organic compound for precise and safe labeling.

Innovation Solution

A compound represented by Chemical Formulas 1 or 2 is synthesized through reactions involving acetonitrile, potassium iodide, pyridine, and other reagents to form a BODIPY derivative that specifically labels mitochondria, allowing for precise and gene-mutation-free labeling.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If green fluorescence protein (GFP) is used for labeling mitochondria, then fluorescence labeling is achieved, but gene mutation risk increases due to large virus size and random DNA injection

Engineering Contradiction:
Improvelabeling safetyVSAvoidgene mutation risk
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The invention extracts only the essential fluorescent labeling function from the GFP system, replacing the large protein-based approach with a small-molecule organic compound that achieves mitochondrial labeling without requiring viral transfection or DNA injection, thereby eliminating gene mutation risks

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent employs a small-molecule organic compound that can be easily introduced into cells and degraded naturally, replacing the persistent genetic modification approach with a transient, non-integrating fluorescent probe that avoids long-term genetic risks

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

2Measurement precision

If green fluorescence protein (GFP) is used for labeling mitochondria, then fluorescence labeling is achieved, but resolution is limited due to large molecular size

Engineering Contradiction:
Improvelabeling resolutionVSAvoidmolecular size
Core Design Contradiction:
Measurement precisionVSWeight of moving object

Solution Approach 1:

The patent employs a small-molecule organic compound that can be easily introduced into cells and degraded naturally, replacing the persistent genetic modification approach with a transient, non-integrating fluorescent probe that avoids long-term genetic risks

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The synthesized compound effectively labels mitochondria, as demonstrated by fluorescence microscopy, providing high-resolution imaging without the risks associated with traditional methods, and is suitable for cancer research and diagnosis.

Implementation Method 1

the resolution is limited due to the large size of about 27 kDa and because the virus is characterized in that its traits are randomly injected into the DNA of the infectious agent

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Data Source

PatentUS10100065B2Compound for labeling mitochondria and method of producing the same
Publication Date: 2018.10.16 KOREA INST OF SCI & TECH
  • US10100065B2 patent drawing
  • US10100065B2 patent drawing
  • US10100065B2 patent drawing

AI summary

This invention relates to a compound for labeling mitochondria and a method of producing the same, wherein the compound is represented by Chemical Formula 1 or Chemical Formula 2 below, and is useful in labeling mitochondria.In Chemical Formulas 1 and 2, n is 4 or 10.